Biocode Technologies researches, incubates and commercialises inflammation-centred medical technologies. They concentrate specifically on diagnostic solutions that contribute to the management and improvement of human health and wellbeing. Their expanding brand family currently comprises Biocheck, which focuses on rapid testing, and Biolab, which focuses on diagnostic methodologies.

African Applied Chemical (Pty) Ltd is a bio-technology company that specialises in the manufacture of a proprietary slow release fibres (Bi-KoTM). These fibres are made mainly from polypropylene copolymer. The fibres are specially engineered to store a high amount of liquid within their matrix and slowly release small amounts over a long period of time.

This technology is aimed at slowly releasing high value actives in order to prolong their residual effectiveness and reduce the overall cost of their use in practical applications. 

CapeBio Technologies intends to develop a state-of-the-art AI platform to mine metagenomic data for novel antimicrobial peptide genes. This is a machine-learning and data-science-driven application that allows for better and novel detection of medically important genes that can be used to fight diseases such as cancer and tuberculosis.

Hyrax Biosciences is an award-winning genetic software company that takes the complexity out of sequence data analysis for companies around the world. Its automated platform, Exatype, a leading bioinformatics software platform, combines scalable tech and unique algorithms to deliver detailed and accurate genotype reports, without the need for human intervention or the threat of human error.